Priority Date: 22.03.12 (US 201261614438P)

APTAMERS TO TISSUE FACTOR PATHWAY INHIBITOR AND THEIR USE AS BLEEDING DISORDER THERAPEUTICS

  • Application ID: EP13712634
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING) is specialized in the combination A61 and G01. We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Dr. Emil Benatov & Partners - Bulgarian Patent Attorney & Licensed Appraiser and 172 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 22.03.2012 - Priority Date (US 201261614438P)
  • 26.09.2013 - Publication A2 (WO2013142153)
  • 28.01.2015 - Publication A2 (EP2827910)